Loading...
XWAR
ICE
Market cap133mUSD
Oct 09, Last price  
60.50PLN
1D
3.88%
1Q
-29.22%
IPO
467.68%
Name

Medinice SA

Chart & performance

D1W1MN
XWAR:ICE chart
P/E
—
P/S
—
EPS
—
Div yield, %
—
Shrs. gr., 5y
9.51%
Rev. gr., 5y
2.72%
Revenues
0
-100.00%
184,743243,0351,110164,388372,000288,000246,000225,000188,0000
Net income
-7m
L
000-2,246,239-3,021,000-2,883,000-4,925,000-5,072,00037,577,000-6,723,000
CFO
-6m
L+52.79%
000-5,136,151-3,264,000-1,682,000-2,788,000-3,447,000-3,654,000-5,583,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Established in 2012 and headquartered in Warsaw, Poland, Medinice S.A. specializes in delivering advanced medical solutions for the fields of cardiology and cardiac surgery. The company actively assists scientists in the complex journey of bringing new products to market, offering comprehensive support that spans prototyping, conducting clinical trials, securing essential certifications, and overseeing product sales.
URL
https://www.medinice.pl/
IPO date
Sep 25, 2018
Employees
14
Domiciled in
PL
Incorporated in
PL
Headquarters & legal address
WARSZAWA HANKIEWICZA 2
WARSZAWA, 14 02-103
PL

Valuation

Title
PLN in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT